Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study

Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study

Abstract Objective Duchenne muscular dystrophy (DMD) is an X‐linked disorder resulting in progressive muscle weakness and atrophy, cardiomyopathy, and in late stages, cardiorespiratory impairment, and death. As treatments for DMD have expanded, a DMD newborn screening (NBS) pilot study was conducted...

Full description

Bibliographic Details
Main Authors: Norma P. Tavakoli, Dorota Gruber, Niki Armstrong, Wendy K. Chung, Breanne Maloney, Sunju Park, Julia Wynn, Carrie Koval‐Burt, Lorraine Verdade, David H. Tegay, Lilian L. Cohen, Natasha Shapiro, Annie Kennedy, Garey Noritz, Emma Ciafaloni, Barry Weinberger, Marty Ellington Jr, Charles Schleien, Regina Spinazzola, Sunil Sood, Amy Brower, Michele Lloyd‐Puryear, Michele Caggana, the Duchenne Muscular Dystrophy Pilot Study Group
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51829

Similar Items

Similar Items